New Light-Based test could predict best treatment for leg artery disease

NCT ID NCT07313410

Recruiting now Knowledge-focused Sponsor: The University of Texas at Arlington Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to better understand how blood flow and oxygen use in the legs are affected in people with peripheral artery disease (PAD). Researchers will use a non-invasive device that shines near-infrared light on the leg to measure oxygen levels. The study will include 120 participants, both with and without PAD, and will track walking ability, quality of life, and treatment outcomes over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors better predict which treatments work best for individual patients with peripheral artery disease.
What could go wrong: This is an observational study, not a treatment trial. It will not directly improve health, and results may not lead to immediate changes in care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERY DISEASE (PAD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

peripheral arterial disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PERIPHERAL ARTERY DISEASE (PAD)

Contacts and locations

Locations

University of Texas Arlington
NOT_YET_RECRUITING

Arlington, Texas, 76019, United States
University of Texas at Arlington
RECRUITING

Arlington, Texas, 76010, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.